Novel Bispecific Degrader BHV-1300 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models Including Nonhuman Primates (S43.004)
Bunin A, Lee S, Kazmierski W, McGrath K, Rossi A, Nicholson S, Dubowchik G, Dierks E, Sharpe N, Pirman D, Car B, Qureshi I, Coric V, Spiegel D. Novel Bispecific Degrader BHV-1300 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models Including Nonhuman Primates (S43.004). Neurology 2024, 102 DOI: 10.1212/wnl.0000000000206715.Peer-Reviewed Original ResearchNonhuman primates